BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Doxorubicin
,
rs2230926
,
DNMT1
,
T cell receptor signaling pathway
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Gata 1
Summary
General Info
Curated Studies
Most Correlated Studies
G1ME pluripotent hematopoitic stem cells expressing wildtype and mutant GATA-1
Expression profiling of GATA-1 wild type and mutant fetal megakaryocytes
SetD8 Knockdown in ß- estradiol-treated (24 h) G1E-ER-GATA-1 cells
Cadiac GATA-4 overexpression in Rats
Bone marrow FDCP-mix cells timecourse differentiation into erythroid or myeloid lineages
Explore Curated Studies Results
Literature
Most Relevant Literature
Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis.
Gata1s mutant mice display persistent defects in the erythroid lineage.
A novel GATA1 variant p.G229D causing the defect of procoagulant platelet formation.
Generation of CHOPi-008-B, a euploid iPSC line from a patient with Trisomy 21 and a GATA1 mutation.
Generation of 2 isogenic clones from a patient with Trisomy 21 and a GATA1 mutation.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Ast…
Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Canc…
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Br…
Effect and Prognosis of Immunohistochemical Biomarkers Changes in Patients With Bladder Cancer After…
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ